As part of a trade agreement reached Sunday between the U.S. and the European Union, pharmaceutical imports—along with almost all goods entering the U.S. from the bloc—will be subject to a 15% tariff, according to a White House fact sheet
read moreNovo Nordisk has named Maziar Mike Doustdar, currently the company’s EVP of international operations, as the new CEO. More: Novo Nordisk names new CEO as the obesity drugmaker cuts sales, profit outlook Source: fierce
read moreAs interest in injectable biologics for cancer and other diseases continues to surge, CDMO Simtra BioPharma Solutions is catching the wave with plans for a new commercial manufacturing project in the U.S. More: Eyeing commercial ADC capacity, injectables specialist Simtra
read moreA recently launched video series from the Biotechnology Innovation Organization seeks to show how biotech may be able to solve some of the most pressing challenges facing the world today. More: Chiesi, Viatris among collaborators on BIO’s latest BBC-produced video
read moreWith the HHS secretary reportedly considering wiping USPSTF members, existing PrEP coverage recommendations and future calls on Gilead’s newly launched Yeztugo could be in jeopardy. More: With RFK Jr. reportedly weighing preventative services panel revamp, HIV PrEP drugmakers could be
read moreAfter months of searching for strategic options, Adaptimmune is offloading its cell therapies to a global pharma, which plans to offer jobs to about half of the biotech’s employees. Once the deal closes, Adaptimmune will reduce its remaining workforce by
read more© 1994 - 2025 B.M. Pharmaceuticals